high-dose intravenous immunoglobulin is being used increasingly as a new therapeutic approach towards various autoimmune diseases , yielding encouraging results predominantly in idiopathic thrombocytopenic purpura ( itp ) .
C0004364
autoimmune diseases
C0398650
idiopathic thrombocytopenic purpura